nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—KCNH2—Sunitinib—pancreatic cancer	0.128	0.512	CbGbCtD
Quinidine barbiturate—CYP2D6—Tamoxifen—pancreatic cancer	0.0539	0.215	CbGbCtD
Quinidine barbiturate—CYP2D6—Erlotinib—pancreatic cancer	0.0459	0.183	CbGbCtD
Quinidine barbiturate—CYP2D6—Doxorubicin—pancreatic cancer	0.0226	0.0902	CbGbCtD
Quinidine barbiturate—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000631	0.000861	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Epirubicin—pancreatic cancer	0.000628	0.000856	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000627	0.000854	CcSEcCtD
Quinidine barbiturate—Pain—Gemcitabine—pancreatic cancer	0.000625	0.000852	CcSEcCtD
Quinidine barbiturate—Constipation—Gemcitabine—pancreatic cancer	0.000625	0.000852	CcSEcCtD
Quinidine barbiturate—Nausea—Erlotinib—pancreatic cancer	0.000625	0.000852	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Fluorouracil—pancreatic cancer	0.000625	0.000852	CcSEcCtD
Quinidine barbiturate—Mood swings—Doxorubicin—pancreatic cancer	0.000624	0.000851	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Sunitinib—pancreatic cancer	0.000624	0.00085	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000621	0.000846	CcSEcCtD
Quinidine barbiturate—Ataxia—Doxorubicin—pancreatic cancer	0.00062	0.000845	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000619	0.000843	CcSEcCtD
Quinidine barbiturate—Asthma—Epirubicin—pancreatic cancer	0.000615	0.000839	CcSEcCtD
Quinidine barbiturate—Pain—Fluorouracil—pancreatic cancer	0.000615	0.000838	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000614	0.000837	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000608	0.000829	CcSEcCtD
Quinidine barbiturate—Dizziness—Sunitinib—pancreatic cancer	0.000603	0.000822	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000603	0.000821	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000602	0.00082	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000602	0.00082	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Epirubicin—pancreatic cancer	0.0006	0.000817	CcSEcCtD
Quinidine barbiturate—Breast disorder—Doxorubicin—pancreatic cancer	0.000595	0.000812	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Irinotecan—pancreatic cancer	0.000593	0.000809	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Irinotecan—pancreatic cancer	0.000593	0.000809	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000593	0.000809	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000592	0.000808	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Epirubicin—pancreatic cancer	0.000584	0.000797	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Doxorubicin—pancreatic cancer	0.000581	0.000792	CcSEcCtD
Quinidine barbiturate—Vomiting—Sunitinib—pancreatic cancer	0.000579	0.00079	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000578	0.000788	CcSEcCtD
Quinidine barbiturate—Neutropenia—Epirubicin—pancreatic cancer	0.000576	0.000785	CcSEcCtD
Quinidine barbiturate—Rash—Sunitinib—pancreatic cancer	0.000575	0.000783	CcSEcCtD
Quinidine barbiturate—Dermatitis—Sunitinib—pancreatic cancer	0.000574	0.000783	CcSEcCtD
Quinidine barbiturate—Urticaria—Fluorouracil—pancreatic cancer	0.000571	0.000779	CcSEcCtD
Quinidine barbiturate—Headache—Sunitinib—pancreatic cancer	0.000571	0.000778	CcSEcCtD
Quinidine barbiturate—Syncope—Docetaxel—pancreatic cancer	0.00057	0.000777	CcSEcCtD
Quinidine barbiturate—Asthma—Doxorubicin—pancreatic cancer	0.000569	0.000776	CcSEcCtD
Quinidine barbiturate—Leukopenia—Docetaxel—pancreatic cancer	0.000569	0.000776	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000568	0.000775	CcSEcCtD
Quinidine barbiturate—Palpitations—Docetaxel—pancreatic cancer	0.000562	0.000766	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000562	0.000766	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Docetaxel—pancreatic cancer	0.000559	0.000762	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Doxorubicin—pancreatic cancer	0.000555	0.000756	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000553	0.000754	CcSEcCtD
Quinidine barbiturate—Convulsion—Docetaxel—pancreatic cancer	0.000551	0.000751	CcSEcCtD
Quinidine barbiturate—Drowsiness—Epirubicin—pancreatic cancer	0.000549	0.000748	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000544	0.000742	CcSEcCtD
Quinidine barbiturate—Arthralgia—Docetaxel—pancreatic cancer	0.000541	0.000738	CcSEcCtD
Quinidine barbiturate—Myalgia—Docetaxel—pancreatic cancer	0.000541	0.000738	CcSEcCtD
Quinidine barbiturate—Chest pain—Docetaxel—pancreatic cancer	0.000541	0.000738	CcSEcCtD
Quinidine barbiturate—Nausea—Sunitinib—pancreatic cancer	0.000541	0.000738	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Doxorubicin—pancreatic cancer	0.000541	0.000737	CcSEcCtD
Quinidine barbiturate—Renal failure—Epirubicin—pancreatic cancer	0.000539	0.000735	CcSEcCtD
Quinidine barbiturate—Asthenia—Irinotecan—pancreatic cancer	0.000539	0.000734	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000538	0.000733	CcSEcCtD
Quinidine barbiturate—Jaundice—Epirubicin—pancreatic cancer	0.000535	0.000729	CcSEcCtD
Quinidine barbiturate—Neutropenia—Doxorubicin—pancreatic cancer	0.000533	0.000726	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00053	0.000722	CcSEcCtD
Quinidine barbiturate—Sweating—Epirubicin—pancreatic cancer	0.000526	0.000717	CcSEcCtD
Quinidine barbiturate—Asthenia—Gemcitabine—pancreatic cancer	0.000525	0.000715	CcSEcCtD
Quinidine barbiturate—Confusional state—Docetaxel—pancreatic cancer	0.000523	0.000713	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00052	0.000709	CcSEcCtD
Quinidine barbiturate—Oedema—Docetaxel—pancreatic cancer	0.000519	0.000707	CcSEcCtD
Quinidine barbiturate—Pruritus—Gemcitabine—pancreatic cancer	0.000517	0.000705	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Irinotecan—pancreatic cancer	0.000514	0.0007	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Epirubicin—pancreatic cancer	0.000512	0.000698	CcSEcCtD
Quinidine barbiturate—Shock—Docetaxel—pancreatic cancer	0.000511	0.000696	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000509	0.000694	CcSEcCtD
Quinidine barbiturate—Pruritus—Fluorouracil—pancreatic cancer	0.000509	0.000693	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000508	0.000693	CcSEcCtD
Quinidine barbiturate—Drowsiness—Doxorubicin—pancreatic cancer	0.000508	0.000692	CcSEcCtD
Quinidine barbiturate—Tachycardia—Docetaxel—pancreatic cancer	0.000506	0.00069	CcSEcCtD
Quinidine barbiturate—Skin disorder—Docetaxel—pancreatic cancer	0.000504	0.000687	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000503	0.000686	CcSEcCtD
Quinidine barbiturate—Bradycardia—Epirubicin—pancreatic cancer	0.000502	0.000684	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Gemcitabine—pancreatic cancer	0.0005	0.000682	CcSEcCtD
Quinidine barbiturate—Renal failure—Doxorubicin—pancreatic cancer	0.000499	0.00068	CcSEcCtD
Quinidine barbiturate—Dizziness—Irinotecan—pancreatic cancer	0.000496	0.000677	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Epirubicin—pancreatic cancer	0.000495	0.000675	CcSEcCtD
Quinidine barbiturate—Jaundice—Doxorubicin—pancreatic cancer	0.000495	0.000675	CcSEcCtD
Quinidine barbiturate—Anorexia—Docetaxel—pancreatic cancer	0.000495	0.000674	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Epirubicin—pancreatic cancer	0.000493	0.000672	CcSEcCtD
Quinidine barbiturate—Hepatitis—Epirubicin—pancreatic cancer	0.000493	0.000672	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000492	0.000671	CcSEcCtD
Quinidine barbiturate—Sweating—Doxorubicin—pancreatic cancer	0.000487	0.000664	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000487	0.000663	CcSEcCtD
Quinidine barbiturate—Hypotension—Docetaxel—pancreatic cancer	0.000485	0.000661	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Epirubicin—pancreatic cancer	0.000483	0.000658	CcSEcCtD
Quinidine barbiturate—Vomiting—Irinotecan—pancreatic cancer	0.000477	0.000651	CcSEcCtD
Quinidine barbiturate—Dizziness—Fluorouracil—pancreatic cancer	0.000475	0.000648	CcSEcCtD
Quinidine barbiturate—Visual impairment—Epirubicin—pancreatic cancer	0.000475	0.000647	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000474	0.000646	CcSEcCtD
Quinidine barbiturate—Rash—Irinotecan—pancreatic cancer	0.000473	0.000645	CcSEcCtD
Quinidine barbiturate—Dermatitis—Irinotecan—pancreatic cancer	0.000473	0.000645	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000473	0.000644	CcSEcCtD
Quinidine barbiturate—Headache—Irinotecan—pancreatic cancer	0.00047	0.000641	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Epirubicin—pancreatic cancer	0.000466	0.000635	CcSEcCtD
Quinidine barbiturate—Vomiting—Gemcitabine—pancreatic cancer	0.000465	0.000634	CcSEcCtD
Quinidine barbiturate—Bradycardia—Doxorubicin—pancreatic cancer	0.000464	0.000633	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Docetaxel—pancreatic cancer	0.000463	0.000631	CcSEcCtD
Quinidine barbiturate—Somnolence—Docetaxel—pancreatic cancer	0.000461	0.000629	CcSEcCtD
Quinidine barbiturate—Rash—Gemcitabine—pancreatic cancer	0.000461	0.000629	CcSEcCtD
Quinidine barbiturate—Dermatitis—Gemcitabine—pancreatic cancer	0.000461	0.000628	CcSEcCtD
Quinidine barbiturate—Eye disorder—Epirubicin—pancreatic cancer	0.00046	0.000628	CcSEcCtD
Quinidine barbiturate—Tinnitus—Epirubicin—pancreatic cancer	0.000459	0.000626	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000458	0.000625	CcSEcCtD
Quinidine barbiturate—Headache—Gemcitabine—pancreatic cancer	0.000458	0.000624	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Epirubicin—pancreatic cancer	0.000457	0.000623	CcSEcCtD
Quinidine barbiturate—Flushing—Epirubicin—pancreatic cancer	0.000457	0.000623	CcSEcCtD
Quinidine barbiturate—Vomiting—Fluorouracil—pancreatic cancer	0.000457	0.000623	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000456	0.000621	CcSEcCtD
Quinidine barbiturate—Hepatitis—Doxorubicin—pancreatic cancer	0.000456	0.000621	CcSEcCtD
Quinidine barbiturate—Rash—Fluorouracil—pancreatic cancer	0.000453	0.000618	CcSEcCtD
Quinidine barbiturate—Dermatitis—Fluorouracil—pancreatic cancer	0.000453	0.000617	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Docetaxel—pancreatic cancer	0.000451	0.000615	CcSEcCtD
Quinidine barbiturate—Headache—Fluorouracil—pancreatic cancer	0.00045	0.000614	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00045	0.000614	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000448	0.000611	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000447	0.000609	CcSEcCtD
Quinidine barbiturate—Nausea—Irinotecan—pancreatic cancer	0.000446	0.000608	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Epirubicin—pancreatic cancer	0.000445	0.000607	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000444	0.000605	CcSEcCtD
Quinidine barbiturate—Pain—Docetaxel—pancreatic cancer	0.000444	0.000605	CcSEcCtD
Quinidine barbiturate—Constipation—Docetaxel—pancreatic cancer	0.000444	0.000605	CcSEcCtD
Quinidine barbiturate—Chills—Epirubicin—pancreatic cancer	0.000442	0.000603	CcSEcCtD
Quinidine barbiturate—Visual impairment—Doxorubicin—pancreatic cancer	0.000439	0.000599	CcSEcCtD
Quinidine barbiturate—Nausea—Gemcitabine—pancreatic cancer	0.000434	0.000592	CcSEcCtD
Quinidine barbiturate—Mental disorder—Epirubicin—pancreatic cancer	0.000432	0.000588	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000431	0.000588	CcSEcCtD
Quinidine barbiturate—Erythema—Epirubicin—pancreatic cancer	0.000429	0.000585	CcSEcCtD
Quinidine barbiturate—Malnutrition—Epirubicin—pancreatic cancer	0.000429	0.000585	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000428	0.000583	CcSEcCtD
Quinidine barbiturate—Nausea—Fluorouracil—pancreatic cancer	0.000427	0.000582	CcSEcCtD
Quinidine barbiturate—Eye disorder—Doxorubicin—pancreatic cancer	0.000426	0.000581	CcSEcCtD
Quinidine barbiturate—Tinnitus—Doxorubicin—pancreatic cancer	0.000425	0.000579	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000424	0.000578	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000423	0.000577	CcSEcCtD
Quinidine barbiturate—Flushing—Doxorubicin—pancreatic cancer	0.000423	0.000577	CcSEcCtD
Quinidine barbiturate—Tension—Epirubicin—pancreatic cancer	0.000421	0.000574	CcSEcCtD
Quinidine barbiturate—Nervousness—Epirubicin—pancreatic cancer	0.000417	0.000568	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000412	0.000561	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000411	0.00056	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Docetaxel—pancreatic cancer	0.00041	0.000559	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Docetaxel—pancreatic cancer	0.00041	0.000559	CcSEcCtD
Quinidine barbiturate—Chills—Doxorubicin—pancreatic cancer	0.000409	0.000558	CcSEcCtD
Quinidine barbiturate—Vision blurred—Epirubicin—pancreatic cancer	0.000404	0.000551	CcSEcCtD
Quinidine barbiturate—Mental disorder—Doxorubicin—pancreatic cancer	0.000399	0.000544	CcSEcCtD
Quinidine barbiturate—Malnutrition—Doxorubicin—pancreatic cancer	0.000397	0.000541	CcSEcCtD
Quinidine barbiturate—Erythema—Doxorubicin—pancreatic cancer	0.000397	0.000541	CcSEcCtD
Quinidine barbiturate—Agitation—Epirubicin—pancreatic cancer	0.000394	0.000537	CcSEcCtD
Quinidine barbiturate—Tension—Doxorubicin—pancreatic cancer	0.000389	0.000531	CcSEcCtD
Quinidine barbiturate—Nervousness—Doxorubicin—pancreatic cancer	0.000385	0.000525	CcSEcCtD
Quinidine barbiturate—Vertigo—Epirubicin—pancreatic cancer	0.000385	0.000525	CcSEcCtD
Quinidine barbiturate—Syncope—Epirubicin—pancreatic cancer	0.000385	0.000524	CcSEcCtD
Quinidine barbiturate—Leukopenia—Epirubicin—pancreatic cancer	0.000384	0.000523	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000382	0.000521	CcSEcCtD
Quinidine barbiturate—Palpitations—Epirubicin—pancreatic cancer	0.000379	0.000517	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000377	0.000514	CcSEcCtD
Quinidine barbiturate—Vision blurred—Doxorubicin—pancreatic cancer	0.000374	0.00051	CcSEcCtD
Quinidine barbiturate—Asthenia—Docetaxel—pancreatic cancer	0.000372	0.000508	CcSEcCtD
Quinidine barbiturate—Convulsion—Epirubicin—pancreatic cancer	0.000372	0.000507	CcSEcCtD
Quinidine barbiturate—Pruritus—Docetaxel—pancreatic cancer	0.000367	0.0005	CcSEcCtD
Quinidine barbiturate—Myalgia—Epirubicin—pancreatic cancer	0.000365	0.000498	CcSEcCtD
Quinidine barbiturate—Arthralgia—Epirubicin—pancreatic cancer	0.000365	0.000498	CcSEcCtD
Quinidine barbiturate—Chest pain—Epirubicin—pancreatic cancer	0.000365	0.000498	CcSEcCtD
Quinidine barbiturate—Agitation—Doxorubicin—pancreatic cancer	0.000365	0.000497	CcSEcCtD
Quinidine barbiturate—Anxiety—Epirubicin—pancreatic cancer	0.000364	0.000496	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000363	0.000494	CcSEcCtD
Quinidine barbiturate—Vertigo—Doxorubicin—pancreatic cancer	0.000357	0.000486	CcSEcCtD
Quinidine barbiturate—Syncope—Doxorubicin—pancreatic cancer	0.000356	0.000485	CcSEcCtD
Quinidine barbiturate—Leukopenia—Doxorubicin—pancreatic cancer	0.000355	0.000484	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Docetaxel—pancreatic cancer	0.000355	0.000484	CcSEcCtD
Quinidine barbiturate—Confusional state—Epirubicin—pancreatic cancer	0.000353	0.000481	CcSEcCtD
Quinidine barbiturate—Palpitations—Doxorubicin—pancreatic cancer	0.000351	0.000478	CcSEcCtD
Quinidine barbiturate—Oedema—Epirubicin—pancreatic cancer	0.00035	0.000477	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000349	0.000475	CcSEcCtD
Quinidine barbiturate—Shock—Epirubicin—pancreatic cancer	0.000344	0.000469	CcSEcCtD
Quinidine barbiturate—Convulsion—Doxorubicin—pancreatic cancer	0.000344	0.000469	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000343	0.000468	CcSEcCtD
Quinidine barbiturate—Dizziness—Docetaxel—pancreatic cancer	0.000343	0.000468	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000343	0.000467	CcSEcCtD
Quinidine barbiturate—Tachycardia—Epirubicin—pancreatic cancer	0.000342	0.000466	CcSEcCtD
Quinidine barbiturate—Skin disorder—Epirubicin—pancreatic cancer	0.00034	0.000463	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000338	0.000461	CcSEcCtD
Quinidine barbiturate—Myalgia—Doxorubicin—pancreatic cancer	0.000338	0.000461	CcSEcCtD
Quinidine barbiturate—Chest pain—Doxorubicin—pancreatic cancer	0.000338	0.000461	CcSEcCtD
Quinidine barbiturate—Arthralgia—Doxorubicin—pancreatic cancer	0.000338	0.000461	CcSEcCtD
Quinidine barbiturate—Anxiety—Doxorubicin—pancreatic cancer	0.000337	0.000459	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000335	0.000457	CcSEcCtD
Quinidine barbiturate—Anorexia—Epirubicin—pancreatic cancer	0.000334	0.000455	CcSEcCtD
Quinidine barbiturate—Vomiting—Docetaxel—pancreatic cancer	0.00033	0.00045	CcSEcCtD
Quinidine barbiturate—Rash—Docetaxel—pancreatic cancer	0.000327	0.000446	CcSEcCtD
Quinidine barbiturate—Hypotension—Epirubicin—pancreatic cancer	0.000327	0.000446	CcSEcCtD
Quinidine barbiturate—Dermatitis—Docetaxel—pancreatic cancer	0.000327	0.000446	CcSEcCtD
Quinidine barbiturate—Confusional state—Doxorubicin—pancreatic cancer	0.000327	0.000445	CcSEcCtD
Quinidine barbiturate—Headache—Docetaxel—pancreatic cancer	0.000325	0.000443	CcSEcCtD
Quinidine barbiturate—Oedema—Doxorubicin—pancreatic cancer	0.000324	0.000441	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000319	0.000435	CcSEcCtD
Quinidine barbiturate—Shock—Doxorubicin—pancreatic cancer	0.000319	0.000434	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000318	0.000433	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000317	0.000432	CcSEcCtD
Quinidine barbiturate—Tachycardia—Doxorubicin—pancreatic cancer	0.000316	0.000431	CcSEcCtD
Quinidine barbiturate—Skin disorder—Doxorubicin—pancreatic cancer	0.000315	0.000429	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000313	0.000427	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Epirubicin—pancreatic cancer	0.000312	0.000425	CcSEcCtD
Quinidine barbiturate—Somnolence—Epirubicin—pancreatic cancer	0.000311	0.000424	CcSEcCtD
Quinidine barbiturate—Anorexia—Doxorubicin—pancreatic cancer	0.000309	0.000421	CcSEcCtD
Quinidine barbiturate—Nausea—Docetaxel—pancreatic cancer	0.000308	0.00042	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Epirubicin—pancreatic cancer	0.000304	0.000415	CcSEcCtD
Quinidine barbiturate—Hypotension—Doxorubicin—pancreatic cancer	0.000303	0.000413	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000302	0.000412	CcSEcCtD
Quinidine barbiturate—Constipation—Epirubicin—pancreatic cancer	0.000299	0.000408	CcSEcCtD
Quinidine barbiturate—Pain—Epirubicin—pancreatic cancer	0.000299	0.000408	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000295	0.000402	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Doxorubicin—pancreatic cancer	0.000289	0.000394	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000288	0.000393	CcSEcCtD
Quinidine barbiturate—Somnolence—Doxorubicin—pancreatic cancer	0.000288	0.000392	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000286	0.00039	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000282	0.000384	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00028	0.000381	CcSEcCtD
Quinidine barbiturate—Urticaria—Epirubicin—pancreatic cancer	0.000278	0.000379	CcSEcCtD
Quinidine barbiturate—Pain—Doxorubicin—pancreatic cancer	0.000277	0.000378	CcSEcCtD
Quinidine barbiturate—Constipation—Doxorubicin—pancreatic cancer	0.000277	0.000378	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Epirubicin—pancreatic cancer	0.000277	0.000377	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Epirubicin—pancreatic cancer	0.000277	0.000377	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000267	0.000364	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000265	0.000361	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000258	0.000352	CcSEcCtD
Quinidine barbiturate—Urticaria—Doxorubicin—pancreatic cancer	0.000257	0.000351	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000256	0.000349	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000256	0.000349	CcSEcCtD
Quinidine barbiturate—Asthenia—Epirubicin—pancreatic cancer	0.000251	0.000342	CcSEcCtD
Quinidine barbiturate—Pruritus—Epirubicin—pancreatic cancer	0.000248	0.000338	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Epirubicin—pancreatic cancer	0.000239	0.000326	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000239	0.000325	CcSEcCtD
Quinidine barbiturate—Asthenia—Doxorubicin—pancreatic cancer	0.000232	0.000317	CcSEcCtD
Quinidine barbiturate—Dizziness—Epirubicin—pancreatic cancer	0.000231	0.000316	CcSEcCtD
Quinidine barbiturate—Pruritus—Doxorubicin—pancreatic cancer	0.000229	0.000312	CcSEcCtD
Quinidine barbiturate—Vomiting—Epirubicin—pancreatic cancer	0.000223	0.000303	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000222	0.000302	CcSEcCtD
Quinidine barbiturate—Rash—Epirubicin—pancreatic cancer	0.000221	0.000301	CcSEcCtD
Quinidine barbiturate—Dermatitis—Epirubicin—pancreatic cancer	0.00022	0.000301	CcSEcCtD
Quinidine barbiturate—Headache—Epirubicin—pancreatic cancer	0.000219	0.000299	CcSEcCtD
Quinidine barbiturate—Dizziness—Doxorubicin—pancreatic cancer	0.000214	0.000292	CcSEcCtD
Quinidine barbiturate—Nausea—Epirubicin—pancreatic cancer	0.000208	0.000283	CcSEcCtD
Quinidine barbiturate—Vomiting—Doxorubicin—pancreatic cancer	0.000206	0.000281	CcSEcCtD
Quinidine barbiturate—Rash—Doxorubicin—pancreatic cancer	0.000204	0.000278	CcSEcCtD
Quinidine barbiturate—Dermatitis—Doxorubicin—pancreatic cancer	0.000204	0.000278	CcSEcCtD
Quinidine barbiturate—Headache—Doxorubicin—pancreatic cancer	0.000203	0.000277	CcSEcCtD
Quinidine barbiturate—Nausea—Doxorubicin—pancreatic cancer	0.000192	0.000262	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CASP3—pancreatic cancer	5.59e-05	0.00358	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SSTR3—pancreatic cancer	5.48e-05	0.00351	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CTNNB1—pancreatic cancer	5.38e-05	0.00345	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—EGFR—pancreatic cancer	5.38e-05	0.00344	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SSTR1—pancreatic cancer	5.26e-05	0.00337	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—PPY—pancreatic cancer	5.16e-05	0.0033	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	5.07e-05	0.00324	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SSTR2—pancreatic cancer	5.06e-05	0.00324	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	4.99e-05	0.0032	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	4.99e-05	0.00319	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCKBR—pancreatic cancer	4.89e-05	0.00313	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—SRC—pancreatic cancer	4.87e-05	0.00312	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	4.86e-05	0.00311	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	4.83e-05	0.00309	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	4.79e-05	0.00306	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	4.77e-05	0.00306	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—SST—pancreatic cancer	4.76e-05	0.00305	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HES1—pancreatic cancer	4.73e-05	0.00303	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—STAT3—pancreatic cancer	4.69e-05	0.003	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	4.63e-05	0.00296	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	4.6e-05	0.00295	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	4.46e-05	0.00286	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CNR1—pancreatic cancer	4.39e-05	0.00281	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KDR—pancreatic cancer	4.1e-05	0.00262	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	4.07e-05	0.00261	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	4.05e-05	0.00259	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.01e-05	0.00257	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MET—pancreatic cancer	4.01e-05	0.00257	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SCT—pancreatic cancer	3.98e-05	0.00255	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	3.97e-05	0.00254	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	3.93e-05	0.00251	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCK—pancreatic cancer	3.8e-05	0.00243	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	3.78e-05	0.00242	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	3.75e-05	0.0024	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—SMAD4—pancreatic cancer	3.74e-05	0.00239	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CNR2—pancreatic cancer	3.7e-05	0.00237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GLP1R—pancreatic cancer	3.7e-05	0.00237	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HES1—pancreatic cancer	3.65e-05	0.00234	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCKAR—pancreatic cancer	3.64e-05	0.00233	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—pancreatic cancer	3.62e-05	0.00232	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGF—pancreatic cancer	3.58e-05	0.00229	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.5e-05	0.00224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	3.49e-05	0.00223	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.47e-05	0.00222	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—HRAS—pancreatic cancer	3.42e-05	0.00219	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.42e-05	0.00219	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.37e-05	0.00215	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP2—pancreatic cancer	3.35e-05	0.00214	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SHH—pancreatic cancer	3.32e-05	0.00213	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRLHR—pancreatic cancer	3.31e-05	0.00212	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	3.29e-05	0.0021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—IAPP—pancreatic cancer	3.28e-05	0.0021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	3.22e-05	0.00206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—pancreatic cancer	3.19e-05	0.00204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—PTCH1—pancreatic cancer	3.15e-05	0.00202	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—PTHLH—pancreatic cancer	3.15e-05	0.00202	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	3.15e-05	0.00201	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—SSTR3—pancreatic cancer	3.1e-05	0.00198	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GDI1—pancreatic cancer	3.03e-05	0.00194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GDI2—pancreatic cancer	3.03e-05	0.00194	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	3.03e-05	0.00194	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—AKT1—pancreatic cancer	3.02e-05	0.00194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—SSTR1—pancreatic cancer	2.97e-05	0.0019	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KDR—pancreatic cancer	2.92e-05	0.00187	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PPY—pancreatic cancer	2.91e-05	0.00187	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SST—pancreatic cancer	2.88e-05	0.00184	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MET—pancreatic cancer	2.86e-05	0.00183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—SSTR2—pancreatic cancer	2.86e-05	0.00183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SSTR3—pancreatic cancer	2.81e-05	0.0018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—pancreatic cancer	2.78e-05	0.00178	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCKBR—pancreatic cancer	2.76e-05	0.00177	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NOTCH1—pancreatic cancer	2.75e-05	0.00176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SSTR1—pancreatic cancer	2.7e-05	0.00173	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	2.67e-05	0.00171	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CNR1—pancreatic cancer	2.66e-05	0.0017	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPY—pancreatic cancer	2.65e-05	0.00169	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.63e-05	0.00169	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PPARG—pancreatic cancer	2.6e-05	0.00166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SSTR2—pancreatic cancer	2.6e-05	0.00166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	2.57e-05	0.00165	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GCG—pancreatic cancer	2.57e-05	0.00164	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP9—pancreatic cancer	2.51e-05	0.00161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCKBR—pancreatic cancer	2.51e-05	0.00161	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.47e-05	0.00158	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	2.46e-05	0.00158	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AGTR1—pancreatic cancer	2.45e-05	0.00157	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP2—pancreatic cancer	2.39e-05	0.00153	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GAST—pancreatic cancer	2.38e-05	0.00152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	2.37e-05	0.00152	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—SRC—pancreatic cancer	2.32e-05	0.00148	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	2.29e-05	0.00146	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VEGFA—pancreatic cancer	2.26e-05	0.00145	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—SCT—pancreatic cancer	2.25e-05	0.00144	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—NRAS—pancreatic cancer	2.23e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GAST—pancreatic cancer	2.16e-05	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCK—pancreatic cancer	2.15e-05	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	2.14e-05	0.00137	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.1e-05	0.00135	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CNR2—pancreatic cancer	2.09e-05	0.00134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GLP1R—pancreatic cancer	2.09e-05	0.00134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	2.09e-05	0.00134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCKAR—pancreatic cancer	2.06e-05	0.00132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SCT—pancreatic cancer	2.04e-05	0.00131	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—pancreatic cancer	2.03e-05	0.0013	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—HRAS—pancreatic cancer	2.02e-05	0.00129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRLHR—pancreatic cancer	1.96e-05	0.00125	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCK—pancreatic cancer	1.95e-05	0.00125	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	1.95e-05	0.00125	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KRAS—pancreatic cancer	1.92e-05	0.00123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CNR2—pancreatic cancer	1.9e-05	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GLP1R—pancreatic cancer	1.9e-05	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCKAR—pancreatic cancer	1.87e-05	0.0012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IAPP—pancreatic cancer	1.85e-05	0.00119	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.85e-05	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL8—pancreatic cancer	1.85e-05	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	1.84e-05	0.00118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ZNRF3—pancreatic cancer	1.84e-05	0.00118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ACVR1B—pancreatic cancer	1.84e-05	0.00118	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CTNNB1—pancreatic cancer	1.83e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—pancreatic cancer	1.79e-05	0.00115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	1.79e-05	0.00115	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—HRAS—pancreatic cancer	1.78e-05	0.00114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PTHLH—pancreatic cancer	1.78e-05	0.00114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SHH—pancreatic cancer	1.71e-05	0.00109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	1.69e-05	0.00108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IAPP—pancreatic cancer	1.68e-05	0.00108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SSTR3—pancreatic cancer	1.66e-05	0.00106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DTX1—pancreatic cancer	1.66e-05	0.00106	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—SRC—pancreatic cancer	1.65e-05	0.00106	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—HRAS—pancreatic cancer	1.63e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—SST—pancreatic cancer	1.63e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTHLH—pancreatic cancer	1.62e-05	0.00103	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTCH1—pancreatic cancer	1.62e-05	0.00103	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—pancreatic cancer	1.61e-05	0.00103	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—pancreatic cancer	1.6e-05	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SSTR1—pancreatic cancer	1.59e-05	0.00102	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NRAS—pancreatic cancer	1.59e-05	0.00102	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.58e-05	0.00101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPY—pancreatic cancer	1.56e-05	0.001	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SSTR2—pancreatic cancer	1.53e-05	0.000982	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CNR1—pancreatic cancer	1.5e-05	0.000962	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCKBR—pancreatic cancer	1.48e-05	0.000949	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TGFB1—pancreatic cancer	1.48e-05	0.000947	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SST—pancreatic cancer	1.48e-05	0.000946	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	1.47e-05	0.000943	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GCG—pancreatic cancer	1.45e-05	0.000929	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—pancreatic cancer	1.45e-05	0.000928	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—HRAS—pancreatic cancer	1.42e-05	0.000909	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DTX4—pancreatic cancer	1.39e-05	0.000892	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	1.39e-05	0.000892	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	1.38e-05	0.000886	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—pancreatic cancer	1.38e-05	0.000884	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KRAS—pancreatic cancer	1.37e-05	0.000877	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	1.36e-05	0.000873	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	1.36e-05	0.000868	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	1.36e-05	0.000868	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.33e-05	0.00085	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	1.32e-05	0.000844	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	1.3e-05	0.000835	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GAST—pancreatic cancer	1.27e-05	0.000816	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	1.26e-05	0.000805	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—HRAS—pancreatic cancer	1.21e-05	0.000776	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SCT—pancreatic cancer	1.21e-05	0.000773	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	1.21e-05	0.000773	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HRAS—pancreatic cancer	1.16e-05	0.000745	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCK—pancreatic cancer	1.15e-05	0.000738	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.15e-05	0.000737	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	1.12e-05	0.000719	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	1.12e-05	0.000719	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	1.12e-05	0.000718	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	1.1e-05	0.000707	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	1.07e-05	0.000686	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	1.06e-05	0.000676	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—pancreatic cancer	1.03e-05	0.000658	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SHH—pancreatic cancer	1.01e-05	0.000645	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.01e-05	0.000644	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	1e-05	0.000641	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	9.95e-06	0.000637	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	9.55e-06	0.000611	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	9.55e-06	0.000611	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SST—pancreatic cancer	8.73e-06	0.000559	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.61e-06	0.000551	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	8.55e-06	0.000547	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	8.51e-06	0.000545	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GLP1R—pancreatic cancer	8.11e-06	0.000519	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	8.06e-06	0.000516	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DPYD—pancreatic cancer	7.98e-06	0.000511	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	7.82e-06	0.000501	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GCG—pancreatic cancer	7.78e-06	0.000498	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.57e-06	0.000485	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	7.57e-06	0.000485	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	7.43e-06	0.000475	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STK11—pancreatic cancer	7.32e-06	0.000468	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	6.88e-06	0.00044	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.6e-06	0.000422	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	6.41e-06	0.00041	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	6.34e-06	0.000406	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HES1—pancreatic cancer	6.26e-06	0.000401	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	5.99e-06	0.000384	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CD44—pancreatic cancer	5.86e-06	0.000375	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	5.76e-06	0.000369	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCG—pancreatic cancer	5.62e-06	0.00036	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TERT—pancreatic cancer	5.48e-06	0.000351	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—STK11—pancreatic cancer	5.28e-06	0.000338	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	5.24e-06	0.000336	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	5.23e-06	0.000335	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOE—pancreatic cancer	5.12e-06	0.000328	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KDR—pancreatic cancer	5.02e-06	0.000321	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	4.77e-06	0.000305	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	4.73e-06	0.000302	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	4.62e-06	0.000296	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	4.62e-06	0.000296	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGF—pancreatic cancer	4.57e-06	0.000292	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.55e-06	0.000291	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	4.21e-06	0.000269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	4.06e-06	0.00026	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.02e-06	0.000258	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	3.98e-06	0.000255	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOE—pancreatic cancer	3.7e-06	0.000237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.65e-06	0.000234	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	3.54e-06	0.000227	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	3.4e-06	0.000218	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	3.38e-06	0.000216	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.34e-06	0.000214	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	3.29e-06	0.00021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	3.26e-06	0.000208	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.22e-06	0.000206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	3.17e-06	0.000203	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.14e-06	0.000201	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	3.08e-06	0.000197	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	3.06e-06	0.000196	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	2.98e-06	0.000191	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.93e-06	0.000188	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SRC—pancreatic cancer	2.84e-06	0.000182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	2.76e-06	0.000177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	2.74e-06	0.000175	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	2.73e-06	0.000175	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.56e-06	0.000164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—pancreatic cancer	2.54e-06	0.000163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	2.54e-06	0.000162	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.53e-06	0.000162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	2.49e-06	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.35e-06	0.00015	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.21e-06	0.000141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.16e-06	0.000138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.09e-06	0.000134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2e-06	0.000128	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.76e-06	0.000113	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.56e-06	9.98e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.27e-06	8.15e-05	CbGpPWpGaD
